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ABSTRACT 
In the last decade the hybrid procedure has emerged as an alternative stage I palliation in neonates with hypoplas-
tic left heart syndrome (HLHS). This review discusses the historical aspect, surgical and interventional techniques, 
current outcomes and future direction of this procedure. Hybrid palliation yields equivalent but not superior 
stage I palliation survival and comparable 1-year survival to conventional Norwood palliation, comparable pre-
stage II hemodynamics and pulmonary artery growth, and preserved ventricular function in stage II palliation. 
Hybrid palliation utilizes significantly less resource and shortens postoperative recovery. In comprehensive stage 
II palliation the impact of pulmonary artery reconstruction on subsequent pulmonary artery growth has not been 
determined and should be further investigated. A prospective, randomized trial is warranted to compare these two 
surgical strategies for neonates with hypoplastic left heart syndrome. (Korean Circ J 2010;40:103-111) 
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Introduction 
 
Neonates with hypoplastic left heart syndrome (HL-
HS) and its variants have diminutive left-sided structures 
with systemic outflow obstruction and subsequent duct-
dependent systemic, cerebral, and coronary circulations.
1) 
These anatomic features result in an inherently unsta-
ble physiology, in which the systemic circulation can be 
critically compromised by minor changes in resistances 
of the systemic and/or pulmonary vasculature. The es-
sential aims of stage I palliation in the neonatal period 
are to establish an unobstructed systemic outflow, un-
obstructed intra-atrial communication, and effective pul-
monary blood source. The Norwood procedure has been 
the sole option to achieve these purposes for nearly 20 
years.
2)3) Despite a significant improvement in survival 
after stage I palliation, early mortality remains as high 
as 20-30%
4)5) with significant morbidity, including neu-
rologic injury.
6)7) The high mortality and morbidity stems 
from the following two components: an essentially un-
stable ‘in-parallel’ circulation of Norwood physiology 
with a systemic-to-pulmonary shunt, and surgical stress 
driven by cardiopulmonary bypass (CPB), deep hypoth-
ermic circulatory arrest (DHCA), and the subsequent sys-
temic inflammatory response.   
The hybrid procedure {placement of bilateral pul-
monary artery (PA) bands and a ductal stent} has emerg-
ed in the last decade as an alternative stage I palliation 
for neonates with HLHS.
8-10) The potential but unproven 
advantages of this strategy include avoiding the use of 
CPB, cardioplegic cardiac arrest, and DHCA, which mi-
nimizes the extent of surgery, including the degree of 
the inflammatory response during stage I palliation, th-
ereby improving clinical outcomes. However, there are 
potential disadvantages of the hybrid procedure, includ-
ing the unrepaired hypoplastic aortic arch, which carries 
the risk of malperfusion due to retrograde aortic arch 
obstruction, possible restriction of an intraatrial com-
munication requiring re-intervention, mechanical dis-
tortion of the branch PAs, and significantly greater sur-
gical requirements during comprehensive stage II palliat-
ion. The initial experiences reported high morbidity and 
mortality mainly due to the learning curve of an emerg-
ing strategy.
8)9)11) To date, no significant survival benefit 
of the hybrid approach over the conventional Norwood 
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approach has been reported. Herein we review the his-
tory, surgical and interventional techniques, current out-
comes, and future direction of the hybrid strategy for pa-
tients with HLHS.   
 
Emergence of Hybrid Strategy 
 
Bilateral PA banding was described by Dr. Norwood 
based on his early experience of surgical palliation for 
HLHS before he established the ‘Norwood procedure’
12) 
and has been an option to stabilize critically ill neonates 
with HLHS.
13) This procedure, however, did not become 
a hybrid procedure until ductal stenting became clini-
cally available.   
In the past, maintenance of arterial duct patency in 
patients with duct-dependent pulmonary or systemic 
circulation has only been secured with prostaglandin 
infusion. Extensive animal studies in the early 1990s 
showed the feasibility of stent implantation in the ar-
terial duct to maintain chronic patency.
14) Gibbs et al.
15) 
first reported a combined surgical and interventional 
approach as an alternative to the conventional stage I 
palliation for HLHS in 1993, which consisted of bila-
teral PA banding, surgical or interventional creation of 
an unobstructed intraatrial communication, and stent-
ing of an arterial duct. Two of four patients (50%) died 
within 2 weeks, both of which were related to right ven-
tricular failure. The arterial ducts were both patent, al-
though one had some distal ductal restriction because 
the stent did not cover the entire duct. The nature of 
right ventricular failure was not determined. Their sub-
sequent experience reported in 1999 essentially showed 
similar results: 5 of 8 patients died due to right ventri-
cular failure (4 patients died within 3 months, and 1 pa-
tient died at 30 months; 16). 
They recommended against performing ductal stent-
ing. In 2002, Akintuerk and colleagues
10) reported the 
first successful series involving a ‘hybrid’ approach for 
HLHS in which 9 of 11 patients (81%) were success-
fully palliated with ductal stenting and bilateral PA band-
ing, and subsequently underwent either reconstructive 
surgery or heart transplantation. By the mid-2000s, se-
veral institutes, including our institute, initiated hybrid 
programs as an alternative to the conventional Norwood 
program. 
Neonatal palliation without the use of CPB in pa-
tients with HLHS has been independently developed 
in pediatric heart transplantation programs. In 1993, 
Ruiz et al.
17) reported their experience of ductal stent-
ing as a bridge to transplantation. Four of 5 patients 
(80%) successfully underwent heart transplantation after 
ductal stenting. More recently, Mitchell et al.
18) report-
ed the efficacy of bilateral PA banding as a bridge to 
heart transplantation in order to prevent irreversible pul-
monary vascular disease. 
Indications 
 
There is no consensus or guidelines on hybrid pro-
cedures in patients with HLHS. Every institute has in-
dependently developed the indications for a hybrid pro-
cedure and patient selection. In 2006, Bacha et al.
11) 
reported their initial experience on hybrid stage I pro-
cedures in high-risk neonates. They defined ‘high-risk’ 
as the presence of aortic atresia, severe non-cardiac an-
omalies, low body weight (<2.5 kg), an intact or highly 
restrictive atrial septum, prematurity, and poor ventri-
cular function. Galantowicz et al.,
9)19) who pioneered and 
popularized the hybrid approach, and intended to tr-
eat all neonates with HLHS with a hybrid approach, in-
cluding patients with aortic atresia and/or a diminutive 
aortic arch.   
In The Hospital for Sick Children, our indications 
for the hybrid procedure are all neonates with HLHS, 
including aortic atresia, diminutive aortic arch and/or 
stenotic aortic isthmus. The HLHS variants, such as tri-
cuspid atresia with transposed great arteries, unbalanced 
atrioventricular septal defect with aortic arch obstruc-
tion, or double inlet left ventricle with transposed great 
arteries, are all considered an indication for the hybrid 
procedure. The decision-making process is unique in 
our institute. The type of surgical palliation is typically 
determined through interdisciplinary conferences on a 
case-by-case basis. Staged surgical palliation with the 
standard Norwood approach, hybrid approach, and pri-
mary transplantation are equally offered to the patient’s 
family by the cardiologist, and no specific decision-mak-
ing protocol is applied. Some patients who are consider-
ed at high-risk candidate for the Norwood procedure, 
i.e., neonates with intracranial hemorrhage or extreme 
prematurity and/or low body weight, tend to be treated 
with the hybrid approach. 
 
Aortic atresia with stenotic aortic isthmus retrogra-
de aortic arch 
In patients with aortic atresia, the coronary and ce-
rebral circulations are entirely dependent on retrograde 
blood flow through the aortic isthmus. If there are any 
signs of pre-operative obstruction at the aortic isthmus 
or retrograde aortic arch, deployment of a ductal stent 
can result in acute or chronic obstruction of the aortic 
isthmus, leading to coronary and cerebral ischemia.
20) 
This specific anatomic feature can be a relative con-
traindication for a ‘conventional’ hybrid procedure
21) 
unless specific measures are applied to secure the coro-
nary and cerebral circulations. The following strategies 
have been proposed: 1) prophylactic main PA to inno-
minate artery shunt during stage I palliation {i.e., a ‘re-
verse Blalock-Taussig (BT) shunt’},
20) 2) stent placement 
in the stenotic aortic isthmus, and 3) avoidance of the 
hybrid procedure in favor of the Norwood procedure  
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or transplantation.   
 
Operative Techniques 
 
Stage I palliation 
Hybrid stage I palliation has been previously describ-
ed.
9)10) Herein, the current techniques used in The Hos-
pital for Sick Children are described. The procedure is 
performed in the catheterization laboratory, which is 
referred to as the ‘hybrid suite’. Under general anesthesia, 
a median sternotomy is made and the thymus is resected. 
Bilateral PA banding is achieved using a 3.5 mm poly-
tetrafluoroethylene graft, which is divided longitudinally 
and wrapped around the branch PAs for a width of ap-
proximately 3 mm.   
The bands are then secured to the adventitia of the 
main P A with 5-0 or 6-0 non-absorbable polypropy-
lene sutures to avoid distal dislodging. A vascular clip is 
placed at the proximal edge of the left PA band to guide 
the interventionist for ductal stenting. 
The patient is partially heparinized, a purse-string su-
ture is placed on the main PA, and a 6-Fr sheath is in-
serted. The ductal stent is deployed through the sheath 
under fluoroscopic guidance, achieving stage I pallia-
tion (Figs. 1 and 2). We currently use a self-expanding 
stent, 20 mm in length and 8-10 mm in diameter (eV3 
Protégé; ev3 Endovascular, Inc. Peripheral Vascular, Ply-
mouth, MN, USA). 
Milrinone is commonly used in post-operative care 
to optimize cardiac output and provide systemic vaso-
dilatation. This management strategy stems from our 
early observation that patients who underwent a hy-
brid procedure had diminished cardiac output, high 
systemic vascular resistance, and a high pulmonary-to-
systemic flow ratio (Qp/Qs) despite avoiding CPB/DH-
CA (see Early post-operative physiology)
22) 
In our early experience, atrial septectomies were ty-
pically performed as part of the same procedure; cur-
rently atrial septectomies and stenting are deferred until 
the intra-atrial communication becomes restrictive. 
 
Reverse Blalock-Taussig shunt 
In patients with aortic atresia or those thought to 
have severely restricted prograde aortic flow, a revered 
BT shunt is prophylactically placed from the main PA 
to the innominate artery.
20) After bilateral PA banding 
is achieved, a side-biting clamp is placed on the main 
PA and proximal anastomosis is made using a 3.5 or 4 
mm polytetrafluoroethylene graft on the anterior wall 
of the main PA. Distal anastomosis is then performed 
to the proximal innominate artery with a standard an-
astomotic technique. The flow in the shunt is directed 
from the main PA to the innominate artery. Ductal 
stenting is then performed. 
A  B
C  D
Fig. 1. Angiographic sequence of stent deployment in hybrid stage I palliation. A: the lateral view showing the sheath and guide wire in-
serted via the main PA through the arterial duct. B: pre-stenting angiogram showing unobstructed aortic isthmus and reasonable retro-
grade filling of the aortic arch. C: stent deployment. D: post-stenting angiogram showing reasonable retrograde aortic arch blood flow.  
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Interstage monitoring 
Close monitoring with weekly or biweekly clinic visits 
and echocardiograms are performed. The arm-leg blood 
pressure difference is measured at every clinic visit to 
exclude any signs of aortic arch obstruction. Echocar-
diographic follow-up is particularly focused on the pre-
sence or absence of flow acceleration in the aortic isth-
mus, indicating progression of retrograde aortic arch 
obstruction. The status of the atrial septum is also care-
fully monitored, determining the timing of atrial sep-
tectomy. There are no certain criteria for intervention 
on the atrial septum. The decision is made based on the 
balance between the patient’s clinical status and the 
pressure gradient across the intra-atrial communication. 
A mild-to-moderate pressure gradient up to 8-10 mmHg 
is acceptable as long as the patient is thriving. Prompt 
intervention is required when the patient has symptoms 
of left atrial hypertension, such as poor feeding, an in-
creased respiratory rate, and a decrease in arterial satur-
ation. Ventricular function and atrioventricular valve 
regurgitation are of great importance during the follow-
up echocardiographic examination. Depressed ventricu-
lar function can be a result of retrograde aortic arch 
obstruction in the setting of minimal or no antegrade 
aortic flow, or stenosis of a reverse BT shunt. The pa-
tency and flow pattern of the reverse BT shunt is docu-
mented. Anti-platelet and/or anti-coagulation is in-
dicated only if the patient has a reverse BT shunt. Anti-
platelet therapy is initiated if the patient has a stent 
across the atrial septum. Pre-stage II cardiac catheterizat-
ion is electively performed at 3-4 months of age unless 
intervention for the atrial septum is necessary at an ear-
lier age. 
 
Comprehensive stage II palliation 
Stage II palliation is performed at 4-6 months of age. 
After re-sternotomy, CPB is initiated with the arterial 
cannula placed in the main PA (or on the ascending 
aorta if it is large enough to be cannulated) and bicaval 
cannulations. The patient is cooled in preparation for 
DHCA. The branch PA bands are removed. Cardio-
plegic cardiac arrest is achieved and atrial septectomy is 
performed. Under DHCA with regional cerebral per-
fusion, aortic arch reconstruction is performed using a 
pulmonary homograft patch. A proximal Damus-Kaye-
Stansel anastomosis is achieved with a standard tech-
nique. Branch PAs are enlarged with an autologous pe-
ricardial patch from hilum-to-hilum in most of the 
patients. Finally, bidirectional cavopulmonary shunt is 
achieved with a standard technique in the on-pump 
beating state, while rewarming the patient. The ster-
num can be closed in most of the patients. 
  
The aortic arch reconstruction with a retained st-
ented ductus 
Recently, we have used retained stented duct tissue 
to facilitate aortic arch reconstruction.
23) After DHCA 
is initiated, the main PA is transected (Fig. 3A) and the 
origin of the branch PAs is resected as a single large 
button (Fig. 3B and C). The area of apposition between 
the ascending aorta and the stented ductus is divided 
all the way to the orifice of the aortic isthmus (Fig. 3D). 
All stent material along the posterior aspect of the 
proximal descending aorta is resected. The remaining 
portion of the stented ductus is used as a ‘patch’ for 
aortic arch reconstruction. The aortic arch is reconst-
ructed by sewing the lateral edges of the divided duc-
tus to the divided native aortic arch.   
The potential advantages of this modification are as 
follows: 1) the stented material is already in place, as in 
the natural transverse aortic arch, 2) the continuity be-
tween the ductal material and the descending aorta av-
oids the need for exposure of this area, thereby poten-
tially reducing the risk of bleeding and recurrent la-
ryngeal nerve injury, and 3) avoidance of homograft 
material may improve the potential for future transp-
lantation by avoiding immunologic sensitization. Po-
tential disadvantages include possible aneurysmal for-
mation and recurrent obstruction at the level of the aor-
tic isthmus.   
Fig. 2. A: anterior-posterior view showing post-hybrid configuration. The asterisks represent the site of branch PA bands. B: the black
asterisk showing a guiding vascular clip placed on the proximal edge of the left PA band. PA: pulmonary artery. 
A  B 
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A representative angiogram of the aortic arch recon-
struction using the stented ductus technique is shown 
in Fig. 4. The posterior aspect of the stented ductus 
has a fine natural curve similar to the native aortic arch, 
which increases the amount of space available for the 
left branch PA. 
 
Fontan operation 
The Fontan operation is typically performed at 2-3 
years of age. The timing of surgery and operative tech-
niques used for the Fontan procedure are similar to 
conventional approaches. Briefly, the Fontan connec-
tion is achieved with a 20-24 mm polytetrafluoroethy-
lene tube using an extracardiac technique. The proce-
dure is performed in the on-pump beating state with 
aortic and bicaval cannulation. A 4 mm fenestration 
between the graft and the right-sided atrium is routi-
nely created. An early extubation strategy is applied. 
 
Norwood Versus Hybrid Strategy 
 
Early post-operative physiology 
Comparison of the post-stage I physiology between 
the Norwood and hybrid palliation is of interest within 
the context of very different modes of surgical techni-
ques. The Norwood palliation involves CPB/DHCA and 
results in an in-parallel circulation with a BT shunt. On 
the other hand, hybrid palliation is a less invasive non-
CPB procedure and the native ‘banded’ PAs serves as a 
pulmonary blood source. We compared the early post-
operative physiology between the Norwood (n=13) 
and hybrid stage I (n=6) using respiratory mass spec-
trometry.
22) In the first 48 hours, hybrid patients have 
a lower cardiac output, higher systemic vascular resist-
ance, higher pulmonary-to-systemic flow ratio, decreas-
ed oxygen delivery and consumption, an increased oxy-
gen extraction ratio (Qp/Qs), and an increased lactate 
level (Fig. 5).
22) Those hemodynamic trends reversed 
after 48 hours. Therefore, despite the non-invasive na-
ture of hybrid stage I procedures, there are acute alter-
ations in post-operative physiology which can be clini-
cally significant, especially in patients with limited myo-
cardial reserve. After the first 48 hours, this period of 
diminished oxygen delivery resolves, whereas the Nor-
wood patients have a slower recovery.   
There are some important considerations regarding 
the data. In our institute, early post-operative care for 
Norwood patients is focused on maximal vasodilation 
to secure systemic oxygen delivery and afterload reduc-
tion on the systemic ventricle.
4)24) Therefore, most of 
the Norwood patients receive milrinone and phenoxy-
benzamine. In contrast, aggressive systemic vasodila-
tion therapy is not utilized in the hybrid patients. In light 
of these findings, we currently manage post-operative 
hybrid stage I patients with a strategy which emphasizes 
securing cardiac output and systemic oxygen delivery. 
Some centers advocate performing hybrid stage I 
palliation in a staged manner, which entails separate 
procedures for PA banding and the ductal stenting.
25) 
Schranz et al.
25) suggested that staged palliation may re-
sult in a reduced physiologic injury. Little data is avail-
able to examine this strategy. Currently, we prefer to 
conduct stage I palliation as a single procedure. We do, 
however, advocate deferring atrial septostomy until after 
the patient has recovered from the stage I procedure 
whenever possible. Maintenance of a small gradient ac-
ross the atrial septum is well tolerated during the early 
post-operative period. 
 
Survival 
Initial reports from different centers showed high 
Fig. 3. Modified aortic arch reconstruction in comprehensive st-
age II palliation using a retained stented duct (reproduced with
publisher’s permission). A: main PA division. B and C: resection 
of the branch PAs as a single button. The single arrow showing
the aortic isthmus. D: division of apposition between the ascend-
ing aorta and the stented duct. E: reconstruction of the aortic
arch by sewing the lateral edges of aortic arch and stented duct.
F: reconstructed aortic arch. PA: pulmonary artery. 
A  B  C 
D  E  F 
Fig. 4. The lateral view of aortic arch reconstruction using a re-
tained stented duct. The asterisk showing the left branch PA. PA:
pulmonary artery.  
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mortalities after stage I hybrid palliation, reflecting a 
steep learning curve.
9)11) More recent series, however,  
have demonstrated that hospital survival after stage I 
hybrid palliation ranges from 80-97%. It is important 
to note, however, that some studies excluded high-risk 
patients from the analysis.
10)19)26) Nonetheless, there is 
little published data making a direct comparison in 
survival between Norwood and hybrid palliation. We 
recently published a non-randomized series of Nor-
wood (n=39) and hybrid (n=19) palliation in neonates 
with HLHS and its variants between 2004 and 2007. 
This series included all neonates with all anatomic va-
riants since we initiated the hybrid program. There 
were 4 (21%) operative or interim deaths in the hybrid 
group and 8 (20.5%) deaths in the Norwood group af-
ter stage I palliation (Fig. 6). There was no difference in 
survival between the patients with or without reverse 
BT shunts. Four additional Norwood patients under-
went heart transplantation after the Norwood proce-
dure. There was one (6.6%) late post-operative death 
in the hybrid group. The 1-year survival was equivalent 
between the groups (hybrid 73.7% vs. Norwood 69.2%, 
p=0.83) (Fig. 7).  
 
H y b r i d   g r o u p            N o r w o o d   g r o u p  
Fig. 5. Hemodynamics and oxygen transport parameters after hybrid (n=6) or Norwood procedures (n=13). SAP: systolic arterial pressure,
DAP: diastolic blood pressure, MAP: mean arterial pressure, tPVR: total pulmonary vascular resistance, SVR: systemic vascular resist-
ance, Qp/Qs: pulmonary-to-systemic flow ratio, CO: cardiac output, Qp: pulmonary blood flow, Qs: systemic blood flow, DO2: oxygen 
delivery; VO2: oxygen consumption, ERO2: oxygen extraction ratio (reproduced with publisher’s permission).  
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Pre-stage II hemodynamics and pulmonary artery 
growth 
We reviewed the pre-stage II hemodynamics and PA 
growth between thee Norwood and hybrid groups at 
pre-stage II cardiac catheterization (Table 1). There was 
no difference in the PA pressure between the groups. 
There was a non-significant trend toward a lower ven-
tricular end-diastolic pressure and higher mixed venous 
saturation in the hybrid group compared to the Nor-
wood group (Table 1). There was no difference in Qp/ 
Qs and arterial saturation between the groups. There 
were non-significant trends toward a larger Nakata in-
dex and a lower lobe index in the hybrid group compared 
to the Norwood group. Both groups had equivalent he-
modynamics and PA growth at the pre-stage II evalu-
ation. We have not analyzed the pre-Fontan data in these 
groups. The effect of a newly reconstructed aortic arch 
at the comprehensive stage II palliation on PA growth 
in the hybrid group is uncertain and will be evaluated. 
Ventricular function and atrioventricular valve   
insufficiency 
Progressive systemic ventricular dysfunction is an im-
portant cause of failure in staged single ventricle palli-
ation for patients with HLHS and is a major indica-
tion for heart transplantation. The mechanism of pro-
gressive right ventricular failure in HLHS after the Nor-
wood procedure is not entirely clear, but may be relat-
ed to the following: 1) myocardial damage during stage 
I of the Norwood procedure with cardioplegic cardiac 
arrest and DHCA, 2) persistent volume overload due 
to an inadequately controlled systemic-pulmonary shunt, 
and 3) relatively high afterload on the systemic right 
ventricle. In our study, all 15 patients who had pre-
stage II palliation had normal ventricular function and 
1 patient (6.6%) had significant atrioventricular valve 
insufficiency requiring valve repair during stage II palli-
ation. On the other hand, in the Norwood group, 7 
patients (26%) had mild ventricular dysfunction and 2 
Table 1. Pre-stage II hemodynamics and pulmonary artery growth between Norwood and hybrid groups 
Pre-stage II catheterization  Norwood (n=29)  Hybrid (n=14)  p
Age at catheterization (m)  4.2±1.7 4.3±1.1 0.22
Body weight at catheterization (kg)  5.8±1.1 5.8±1.0 0.693
Ventricular end diastolic pressure (mmHg)  8.8±5.1 6.6±1.5 0.246
Right mean PA pressure (mmHg)  13.2±4.2 11.2±3.2 0.262
Left mean PA pressure (mmHg)  13.5±3.7 13.6±5.5 0.481
Qp/Qs 0.81±0.3 0.83±0.25 0.597
Arterial saturation (%)  74.4±4.5 79±5 0.69
Mixed venous saturation (%)  54.1±7.8 60.6±9.6 0.641
Nakata index  246±126 291±136 0.532
Lower lobe index  123±64 142±41 0.335
Qp/Qs: pulmonary-to-systemic flow ratio 
 
Hybrid stage I 
n=19 
Death 
n=4 
Hybrid stage II 
n=15 
Death 
n=1 
Fontan completed 
n=6 
Awaiting fontan 
n=8 
Norwood 
n=39 
Death 
n=8 
Stage II BCPS 
n=27 
Early death 
n=2 
Fontan completed
n=15 
Awaiting fontan 
n=8 
Transplant 
n=4 
Late death 
n=2 
Fig. 6. Clinical outcomes of the patients undergoing hybrid (n= 
19) or Norwood (n=39) single ventricle palliation. BCPS: bidirec-
tional cavopulmonary shunt. 
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Fig. 7. Kaplan-Meier survival analysis comparing the hybrid and
Norwood groups. There was no difference in 1-year survival (hy-
brid, 73% vs. Norwood, 69%, p=0.83).  
 
110·Hybrid Palliation in Hypoplastic Left Heart Syndrome 
 
patients (7.4%) had severe ventricular dysfunction and 
were listed for transplantation. Four patients (15%) in 
the Norwood group had more than moderate atrioven-
tricular valve insufficiency, of which two underwent valve 
repair.  
It is difficult to reach a strong conclusion regarding 
the impact of the type of palliation and ventricular func-
tion based on our preliminary analysis. Hybrid pallia-
tion avoids neonatal exposure to cardioplegic cardiac ar-
rest, but does not prevent some degree of volume and 
pressure overload to the systemic ventricle. A concern 
unique to hybrid palliation is that because the systemic 
outflow obstruction remains untreated at stage I pallia-
tion, the coronary circulation can be compromised with 
retrograde aortic arch obstruction. Progressive narrow-
ing of the aortic isthmus may result in myocardial ische-
mia and subsequent global ventricular dysfunction. 
We recently observed two patients who underwent hy-
brid stage I and had progressive ventricular dysfunc-
tion during the interim stage. One patient had obstruc-
tion of the aortic isthmus, diminished aortic arch per-
fusion, and myocardial dysfunction with minor nar-
rowing of the reverse BT shunt. Ventricular function 
was improved by the Norwood conversion. Another 
patient had primary systemic right ventricular failure 
with an unknown origin requiring heart transplanta-
tion after stage II palliation. In summary, systemic ven-
tricle in HLHS is at risk of myocardial injury regardless 
of the type of palliation. Hybrid patients appear to have 
better preserved ventricular function at the pre-stage II 
evaluation, but constant surveillance is important. 
 
Impact on neurologic development 
DHCA at the time of the Norwood procedure ne-
gatively affects neurologic development in patients with 
HLHS.
27)28) One of the potential advantages of hybrid 
palliation is to avoid neonatal exposure to DHCA, th-
ereby improving long-term neurologic outcomes. There 
are no data available which compare the hybrid and 
Norwood strategies with a focus on neurologic deve-
lopment. In hybrid palliation, even though DHCA can 
be avoided in the neonatal period, the patients are even-
tually exposed to DHCA at 5-6 months of age. Thus, 
age at the time of DHCA can be tested to identify if there 
is an optimum age to undergo arch reconstruction. It 
is important to recognize that a significant proportion 
of the neonates with HLHS have pre-operative brain 
abnormalities,
29)30) which may be an important cova-
riate in any analysis of neurologic outcomes comparing 
the hybrid and Norwood strategies.   
 
Recourse utilization   
Although survival is the most important measure of 
a palliative strategy, an important secondary parameter 
is hospital resource utilization. In our experience, there 
is a shorter combined (stage I and stage II) intubation 
time, length of intensive care unit stay, and hospital stay 
in the hybrid group compared to the Norwood group.
26) 
Galantowicz et al.
19) showed that the vast majority (85% 
at stage I and II) of the patients were extubated in the 
first 24 hours, indicating much quicker post-operative 
recovery in hybrid patients compared to conventional 
Norwood patients. 
We also found that there are time-related trends to-
wards ongoing improvement in intubation time, inten-
sive care unit stay, and hospital stay for the hybrid stage 
II procedure, indicating that our hybrid palliation stra-
tegy is still on a learning curve with further benefits an-
ticipated as we refine our techniques.
26) These same 
parameters have been unchanged from 2004 to 2007 
in our Norwood palliation experience, suggesting that 
our Norwood palliation strategy is less likely to improve 
in comparison to the hybrid strategy. 
 
Summary 
 
Hybrid palliation for HLHS has dramatically evolv-
ed in the last 5-10 years. The currently available data 
suggest that hybrid palliation offers the following: 1) 
equivalent, but not superior survival at stage I pallia-
tion and subsequently comparable 1-year survival to the 
conventional Norwood palliation, 2) slightly higher, but 
acceptable hospital mortality at stage II palliation, 3) 
comparable pre-stage II hemodynamics and PA growth, 
4) preserved ventricular function at stage II palliation, 
5) significantly less resource utilization and quicker post-
operative recovery, and 6) new innovations (i.e., reverse 
BT shunt and arch reconstruction with a stented arterial 
duct), which appear to be effective, but will require long-
term evaluation. 
Hybrid palliation is an appropriate alternative to the 
conventional Norwood palliation. Our preliminary ex-
perience suggests that a prospective randomized trial is 
warranted to compare the two palliation strategies in 
institutions which have extensive experience with both 
strategies. An important endpoint in any comparison 
will be the impact of surgical palliation on neurologic 
development.  
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